Compound Detail
CHEMBL5095474
EXAGAMGLOGENE AUTOTEMCEL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL5095474 |
| Name | EXAGAMGLOGENE AUTOTEMCEL |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
4
Known Names
4
Indications
1
Mechanisms
Drug Information
| Molecule Type | Gene |
| First Approval | 2023 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| B-cell lymphoma/leukemia 11A gene editing negative modulator | GENE EDITING NEGATIVE MODULATOR | B-cell lymphoma/leukemia 11A | ✓ | ✓ |
Indications
Anemia, Sickle Cell beta-Thalassemia beta-Thalassemia Vaso-Occlusive Crises
ATC Classification
B06AX05
exagamglogene autotemcel
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: OTHER HEMATOLOGICAL AGENTS
Data from ChEMBL 36 via Core Engine